Bevacizumab helped resolve pericardial and pleural effusion that was associated with malignant ovarian clear cell carcinoma

Tomoko Ueda; Hiroshi Tsubamoto; Akiyo Eguchi; Takayuki Terada; Hiroaki Shibahara

首页> 外文期刊>Gynecologic Oncology Reports >Bevacizumab helped resolve pericardial and pleural effusion that was associated with malignant ovarian clear cell carcinoma

【24h】

Bevacizumab helped resolve pericardial and pleural effusion that was associated with malignant ovarian clear cell carcinoma

机译：贝伐单抗帮助解决与恶性卵巢透明细胞癌相关的心包和胸腔积液

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Highlights ? An ovarian clear cell carcinoma patient showed malignant pericardial and pleural effusion. ? She subsequently experienced pulmonary embolism due to cancer progression. ? Pericardial and pleural effusion were successfully treated using bevacizumab.

机译：强调？卵巢透明细胞癌患者表现为恶性心包和胸腔积液。？随后，由于癌症进展，她经历了肺栓塞。？贝伐单抗成功治疗了心包和胸腔积液。

著录项

来源
《Gynecologic Oncology Reports》 |2016年第1期|共3页
作者
Tomoko Ueda; Hiroshi Tsubamoto; Akiyo Eguchi; Takayuki Terada; Hiroaki Shibahara;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Rationale and Design of a Phase II Trial of Osimertinib Combined With Bevacizumab in Patients With Untreated Epidermal Growth Factor Receptor-mutated Non-small-cell Lung Cancer and Malignant Pleural and/or Pericardial Effusion (SPIRAL II Study) [J] . Hiranuma Osamu, Uchino Junji, Yamada Tadaaki, Clinical lung cancer . 2019,第3期

机译：OSIMERTINIB与未处理表皮生长因子受体突变的非小细胞肺癌和恶性胸腔和/或心包积液（螺旋II学习）患者患者II型试验的基础试验
2. Vascular Endothelial Growth Factor in Plasma and Pleural Effusion Is a Biomarker for Outcome After Bevacizumab plus Carboplatin-Paclitaxel Treatment for Non-small Cell Lung Cancer with Malignant Pleural Effusion [J] . Tamiya Motohiro, Tamiya Akihiro, Yasue Tomomi, Anticancer Research: International Journal of Cancer Research and Treatment . 2016,第6期

机译：血浆和胸腔积液中的血管内皮生长因子是贝伐单抗联合卡铂-紫杉醇治疗恶性胸腔积液非小细胞肺癌后结果的生物标志物。
3. A phase II study of bevacizumab with carboplatin-pemetrexed in non-squamous non-small cell lung carcinoma patients with malignant pleural effusions: North East Japan Study Group Trial NEJ013A [J] . Usui Kazuhiro, Sugawara Shunichi, Nishitsuji Masaru, Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2016,第Null期

机译：贝伐单抗联合卡铂培美曲塞治疗非鳞状非小细胞肺癌恶性胸腔积液的II期临床研究：东北日本研究组试验NEJ013A
4. Intra-pleural Cavity hot Saline Perfusion and Intra-pleural Cavity cis-DDPInjection in the Treatment of malignant Pleural Effusion,the Preliminary Observation [C] . The 3rd Asian congress on hyperthermic oncology and the 9th Chineses symposium on hyperthermic oncology . 2002

机译：胸腔内热盐水灌注和胸腔内顺式-DDP注射液治疗恶性胸腔积液的初步观察
5. An economic analysis of the addition of bevacizumab to standard chemotherapy in patients with malignant pleural mesothelioma. [D] . Malacan, Jean. 2016

机译：恶性胸膜间皮瘤患者在标准化疗中加用贝伐单抗的经济分析。
6. Bevacizumab helped resolve pericardial and pleural effusion that was associated with malignant ovarian clear cell carcinoma [O] . Tomoko Ueda, Hiroshi Tsubamoto, Akiyo Eguchi, 2016

机译：贝伐单抗帮助解决与恶性卵巢透明细胞癌相关的心包和胸腔积液
7. Bevacizumab helped resolve pericardial and pleural effusion that was associated with malignant ovarian clear cell carcinoma [O] . Ueda Tomoko, Tsubamoto Hiroshi, Eguchi Akiyo, 2016

机译：贝伐单抗帮助解决与恶性卵巢透明细胞癌相关的心包和胸腔积液

Bevacizumab helped resolve pericardial and pleural effusion that was associated with malignant ovarian clear cell carcinoma

摘要

著录项

相似文献

相关主题

期刊订阅